Shanghai Kaibao Pharmaceutical Capital Reinvestment Ratio
Shanghai Kaibao Pharmaceutical capital reinvestment ratio. Shanghai Kaibao Pharmaceutical (300039) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥190.98 Million) in capital expenditures (CN¥3.37 Million). Check 300039 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Kaibao Pharmaceutical (2006–2025)
Capital reinvestment ratio of Shanghai Kaibao Pharmaceutical from 2006 to 2025. This chart tracks Shanghai Kaibao Pharmaceutical's Capital Reinvestment Ratio across 20 annual periods. Also explore Shanghai Kaibao Pharmaceutical net asset momentum to track the company's year-over-year net asset growth rate.
Shanghai Kaibao Pharmaceutical Capital Reinvestment Ratio by Year (2006–2025)
Shanghai Kaibao Pharmaceutical capital reinvestment ratio by year from 2006 to 2025. For the full cash flow conversion analysis, see Shanghai Kaibao Pharmaceutical cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | CN¥230.74 Million | CN¥27.04 Million | ▼ -76.7% |
| 2024 | 0.50x | CN¥278.95 Million | CN¥140.52 Million | ▲ +563.0% |
| 2023 | 0.08x | CN¥382.66 Million | CN¥29.08 Million | ▼ -9.5% |
| 2022 | 0.08x | CN¥376.42 Million | CN¥31.62 Million | ▼ -75.1% |
| 2021 | 0.34x | CN¥126.08 Million | CN¥42.55 Million | ▲ +506.8% |
| 2020 | 0.06x | CN¥250.65 Million | CN¥13.94 Million | ▲ +20.2% |
| 2019 | 0.05x | CN¥334.09 Million | CN¥15.46 Million | ▼ -53.4% |
| 2018 | 0.10x | CN¥262.36 Million | CN¥26.07 Million | ▼ -50.4% |
| 2017 | 0.20x | CN¥245.76 Million | CN¥49.24 Million | ▲ +133.4% |
| 2016 | 0.09x | CN¥314.88 Million | CN¥27.03 Million | ▼ -44.3% |
| 2015 | 0.15x | CN¥327.08 Million | CN¥50.40 Million | ▼ -36.7% |
| 2014 | 0.24x | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥19.70 Million | CN¥11.74 Million | — |